SCOPE Awards for Anju, EmVenio, Medidata, StudyKIK, uMotif
By Clinical Research News Staff
February 9, 2023 | ORLANDO—Clinical Research News and ClinEco announced the 2023 SCOPE Best of Show awards yesterday at SCOPE. Products from Anju Software, EmVenio, Medidata, StudyKIK, and uMotif took top honors.
The inaugural Best of Show awards at SCOPE invited the more than 3,000 SCOPE attendees to vote on the best new products in the clinical trials and research space. Thirty-five companies exhibiting at the event entered nearly 40 new products launched since February 2022. The new products were on display in the SCOPE Exhibit Hall and event attendees were able to visit booths, see the new products in action, and ask questions before casting their votes for the top new products. The Best of Show competition is sponsored by Clinical Research News and ClinEco, the global clinical trials ecosystem and marketplace.
“Each year at SCOPE the creativity in the clinical research space is so inspiring,” said Clinical Research News editor, Allison Proffitt. “I’m thrilled that the Best of Show awards now formally recognizes those groups leading the charge with innovation.”
“What a wonderful launch year for the Best of Show Awards at SCOPE,” said Gregg Jewett, Director, Alliance Management at Genmab, and a ClinEco strategic advisor. “This first set of winners—chosen by the SCOPE community—represents solutions for some of the most challenging issues facing clinical research: increasing diversity in patient populations and developing platforms that put participant needs first without sacrificing data integrity. Congratulations to the 2023 winners.”
Here are the five products that earned honors this year:
Company: Anju Software
New Product: TA Scan 6 (now with integrated diversity data)
TA Scan is a cloud-based clinical and commercial business intelligence tool that aggregates and connects global clinical trial data, presentation data, publication data, and many other data sources from the public domain into a single intuitive database. TA Scan now has fully integrated diversity data, allowing users to easily streamline their KOL, PI/site selection and diversity strategies, reviewing experience and diversity or socioeconomic data in the same visualization.
New Product: Community Research Site
EmVenio’s Community Research Sites are delivering localized trail access to diverse and underserved communities. The company’s global network of skilled clinicians, principal investigators, and state-of-the-art Community Research sites enables us to provide services via home visits, onsite support at medical facilities, virtual visits, and mobile sites. EmVenio offers multiple Community Research site models with multiple exam rooms and certified lab capabilities.
Company: Medidata, a Dassault Systèmes company
New Product: myMedidata App (v1)
The myMedidata App, launched in December 2022, is a patient-centric, native app designed to provide trial participants with a seamless platform experience and single login for all of their remote trial activities unified with the Medidata Platform, including Rave EDC. The app is configured using Medidata Designer, a new platform configuration tool, bringing a patient-centered mobile-first workflow builder to the myMedidata app.
New Product: StudyCash
StudyCash is an international patient payment application allowing sponsors to easily reimburse patients across the globe, resulting in greater participant accessibility. Patients can operate the application in their native language and select their method of reimbursement in local currency, resulting in greater accessibility and accelerated trials. No physical card is required and no fees are ever charged to the patient. Supported by Auth0 security, StudyCash maintains and meets the requirements of multiple compliance frameworks and certifications including GDPR and HIPAA. Compatible with Android and Apple, StudyCash is available on iOS, Android OS, Windows OS, Mac OS, Chrome, Edge, and Safari.
New Product: uMotif eCOA/ePRO and Engagement Platform
uMotif offers an eClinical cloud native eCOA/ePRO platform for site-based, hybrid and fully decentralized clinical, real-world, and post-marketing research trials. The cornerstone of uMotif’s offering is the Motif – a patented, flower-like graphical user interface to capture PRO, symptom and eDiary data. Each petal of the flower represents a different question, such as an Outcome Measure, symptom, or eDiary entry. Patients simply swipe on the petal to capture their data. It is fast, simple, engaging, accurate, and validated by independent research organization.